HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

nomegestrol acetate

do not confuse with Solastic
Also Known As:
TX 066; TX-066
Networked: 41 relevant articles (5 outcomes, 10 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Pasqualini, Jorge R: 4 articles (12/2010 - 10/2007)
2. Di Carlo, Costantino: 2 articles (10/2015 - 09/2005)
3. Pasqualini, Jorge Raul: 2 articles (02/2009 - 11/2003)
4. Pasqualini, J R: 2 articles (01/2005 - 12/2001)
5. Shields-Botella, J: 2 articles (01/2005 - 11/2003)
6. Tirelli, Alessandra: 1 article (10/2015)
7. Napolitano, Antonella: 1 article (10/2015)
8. Grandi, Giovanni: 1 article (10/2015)
9. Xholli, Anjeza: 1 article (10/2015)
10. Cagnacci, Angelo: 1 article (10/2015)

Related Diseases

1. Noma (Nomas)
2. Hemorrhage
09/01/2000 - "Vaginal bleeding patterns in Nigerian users of nomegestrol acetate subdermal contraceptive implant."
09/01/2000 - "A 12 months longitudinal study was carried out in 214 consecutive Nigerian women using Nomegestrol acetate subdermal contraceptive implant (Uniplant) for the first time to establish the rates of different vaginal bleeding patterns according to WHO bleeding/spotting classification, and to assess their relationship with Uniplant discontinuation. "
12/01/1998 - "This study investigated the efficacy of mifepristone, 10 mg/day for 15 days, followed by nomegestrol acetate (NOMA), 5 mg/day for the next 13 days, for inhibiting ovulation and maintaining regular bleeding cycles in 10 surgically sterilized volunteers. "
12/01/1998 - "The effectiveness of a sequential regimen consisting of mifepristone, 10 mg/day for 15 days, followed by nomegestrol acetate (NOMA), 5 mg/day for the next 13 days, for inhibiting ovulation and maintaining regular bleeding cycles was assessed in 10 surgically sterilized volunteers who were followed for one pretreatment and three treated cycles. "
09/01/2005 - "Patients receiving nomegestrol acetate had a significantly higher incidence of regular progestogen-associated bleeding in comparison with those receiving medroxyprogesterone acetate or natural progesterone, and patients receiving dydrogesterone had a significantly higher incidence of regular progestogen-associated bleeding in comparison with those receiving natural progesterone. "
3. Metrorrhagia (Spotting)
4. Amenorrhea
5. Prostatic Hyperplasia (Benign Prostatic Hyperplasia)

Related Drugs and Biologics

1. Progestins (Progestagens)
2. Mifepristone (RU 486)
3. Progesterone
4. Estradiol (Estrace)
5. 3 (or 17)-beta-hydroxysteroid dehydrogenase
6. estrone sulfatase
7. Hormones
8. Insulin (Novolin)
9. norethindrone acetate (Norlutate)
10. estrone sulfate (Evex)

Related Therapies and Procedures

1. Microspheres (Microsphere)
2. Hormone Replacement Therapy (Therapy, Hormone Replacement)